The timing of altered cRAS and rRAS signaling in AD is unclear (30) but our gene expression data implies that rRAS signaling is dysregulated at end-stage disease following earlier changes in cRAS gene expression, and is therefore likely to be a response (rather than a cause) to overactivation of cRAS signaling. This evidence concerns the gene RRAS and Alzheimer disease.